← FDA Drug Approvals (Drugs@FDA)
RYDAPT
NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2017-04-28
Drug application
- FDA Application #
NDA207997- Application type
- New Drug Application
- Brand name
- RYDAPT
- Generic name
- RYDAPT
- Active ingredients
- MIDOSTAURIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NOVARTIS
- Manufacturer
- Novartis Pharmaceuticals Corporation
- First approval
- 2017-04-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown